Pre-Match Physical of Participant and Referee

 

DEPARTMENT OF BUSINESS AND PROFESSIONAL REGULATION

State Boxing Commission

RULE NO.:RULE TITLE:

61K1-3.016Pre-Match Physical of Participant and Referee

NOTICE OF CHANGE

Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 40 No. 94, May 14, 2014 issue of the Florida Administrative Register.

The changes are in response to concerns stated by the Joint Administrative Procedures Committee in letters dated May 29, 2014. The changes are as follows:

 

61K1-3.016 Pre-Match Physical of Participant and Referee.

(1) Each participant shall, at the time of the weigh-in, be examined by a ringside physician licensed by the Commission who is either a licensed M.D. or D.O. The ringside physician shall certify in writing the participant’s physical condition and a professional assessment as to whether or not the participant may engage in the match. The ringside physician shall, prior to the match, file with the commission representative a written report of the medical examination of the participant, which report shall state whether or not, in the opinion of the ringside physician, the participant is physically fit to engage in the match. No participant shall be permitted to engage in a match unless he or she has been examined and pronounced fit to do so by a ringside physician.

(2) through (3) No change.

(4) No participant shall be allowed to engage in any match if any of the following conditions are found by the physician:

(a) through (e) No change.

(f) Active infectious communicable disease, including skin lesions, such as boils or infected wounds, as well as any other bacterial, viral, fungal, and/or mycobacterial communicable diseases, including tuberculosis;

(g) through (h) No change.

(i) Any indication that the participant is using or is under the influence of a prohibited substance contained within Rule 61K1-3.017, F.A.C. narcotics, drugs, stimulants, depressants, alcohol, local anesthetics or analgesics as to render the participant unable to recognize if the participant is seriously injured. If the physician finds any indication or evidence that the participant is using, is under the influence of unauthorized drugs or foreign substances such that the physician cannot make a definitive determination and therefore allows the match to proceed, the physician shall immediately advise the commission representative who shall ensure that a urine sample is taken and processed in accordance with Rule 61K1-3.017, F.A.C.;

(j) No change.

(k) Ophthalmological problem(s) including but not limited to:

1. Retinopathy or detached retina; provided however, that the applicant shall be permitted to participate in a match if the participant provides, at or before the weigh-in, the written statement of a licensed board certified ophthalmologist stating that the participant’s retina is completely healed and that in the ophthalmologist’s expert medical opinion, no unusual or extraordinary risk to the participant is anticipated as a result of the retinopathy or a previously detached retina;

2. No change.

3. Blindness defined as central visual acuity of 20/200 or less in the better worst eye with 20/40 or worse in the better eye with the best possible correction, possible in both eyes and/or a the widest diameter of the visual field of subtends an angular distance of no greater than 20 degrees or less in the better.

(l) History of epilepsy or seizures, provided however, that the applicant shall be permitted to participate in a match if the participant provides, at or before the weigh-in, the written statement of a board certified neurologist stating that the epilepsy or seizure disorder is well-controlled and that in the neurologist’s expert medical opinion, no unusual or extraordinary risk to the participant is anticipated as a result of the epilepsy or seizure disorder;

(m) History of kidney problems, including solitary kidney; provided however, that the applicant shall be permitted to participate in a match if the participant provides, at or before the weigh-in, the written statement of a licensed board certified nephrologist stating that the kidney problem is resolved and that in the nephrologist’s expert medical opinion, no unusual or extraordinary risk to the participant is anticipated as a result of the resolved kidney problem and/or solitary kidney;

(n) History of blood clotting disorders or abnormal bleeding, including hemophilia and Von Willebrand disease; provided however, that the applicant shall be permitted to participate in a match if the participant provides, at or before the weigh-in, the written statement of a board certified hematologist stating that the bleeding problem is well controlled and that in the hematologist’s expert medical opinion, no unusual or extraordinary risk to the participant is anticipated as a result of the bleeding disorder;

(o) through (q) No change.

(5) Each participant shall be required to submit to any additional medical examination or test ordered by the executive director or his or her designee, or the commission. Such medical examination or test must be must be original or a certified copy of the results which were performed by an M.D., D.O., or laboratory no earlier than 30 days before the date on which the results are presented to the commission, or its executive director or his or her designee.

(6) All participants with cuts and abrasions that require dressing, bandages, or band-aids must be approved to fight by the ringside physician prior to being cleared to participate.

(7) Female participants shall not participate are limited to participation with additional medical restrictions. if If any of the following conditions are identified by the ringside physician during the pre-match physical, the athlete is not permitted to participate:

(a) through (e) No change.

(f) A positive pregnancy test, conducted at the time of the pre-match physical examination. and signed off on by the physician conducting the physical.

(8) The pre-match physical examination shall be documented on Form BPR-0009-455, “Participant Information and Medical Sheet”, effective December March 2014, adopted and incorporated herein by reference, which may be obtained at http://www.myfloridalicense.com/dbpr/pro/sbc/forms.html or http://www.flrules.org/Gateway/refernce.asp?No=Ref-_____, and which shall be completed by the participant and the ringside physician conducting the weigh-in.  Any participant who refuses to complete this form shall not be allowed to engage in any match in Florida.

(9) No change.

(10) Transgender Participants

(a) Transexuals: Male to Female

1. Individuals An individual undergoing sex reassignment from male to female prior to puberty are regarded as women (female) and shall be licensed as such.

2. An individual Individuals undergoing sex reassignment from male to female after puberty may be eligible for participation in female matches under the following conditions:

a. No change.

b. Hormone Therapy, except as otherwise permitted or allowed in this situation, for the assigned sex (female) has been administered for a minimum of two years after gonadectomy by a board-certified endocrinologist, internist, pediatrician, or any physician or any other specialist known to have significant knowledge and experience with transsexual and transgender individuals.  Hormone therapy prior to gonadectomy is not included in the two years due to the potential for the production of endogenous testosterone from the gonads during any period of time when hormone therapy was not available or therapeutically dosed below that which is required to completely suppress testosterone production.

c. Form DBPR FSBC 21, “Therapeutic Use Exemption and Medical Condition Explanation Form,” March 2014, as adopted and incorporated in Rule 61K1-3.007, F.A.C. and a letter from the board certified physician responsible for the care of the participant will need to be submitted to the commission, and shall include the following:

i. Initial date when hormone therapy began for the assigned sex (female) (can be prior to gonadectomy but is not included in the two year requirement for hormone therapy after gonadectomy);

ii. Date, location, surgeon, and surgical report of the gonadectomy (and external genitalia reassignment, if done at the same surgical setting);

iii. Date, location, surgeon, and surgical report for any other surgery involving the genitalia;

iv. Hormone name/type, dose, and interval of administration over the past two years;

v. Lab reports of estradiol and testosterone levels documenting over the past two years that serum estradiol levels are within the normal range for a healthy premenopausal woman and suppression of testosterone levels to those normally found in women, as determined under lab specific ranges as set forth below;

vi. Name, dose, and duration of any anti-androgen treatment used over the past two years;

vii. Name, dose, and duration of any other medication used as part of the management of the transgender state.

(b) Transsexuals: Female to Male.

1. Individuals An individual undergoing sex reassignment from female to male prior to puberty are regarded as boys and eventually men (male) and shall be licensed as such.

2. An individual Individuals undergoing sex reassignments from female to male after puberty may be eligible for participation in male matches under the following conditions:

a. No change.

b. Hormone Therapy for the assigned sex (male) has been administered for a minimum of two years after gonadectomy preferably by a licensed board-certified endocrinologist, internist, pediatrician, or any physician (M.D. or D.O.) known to have significant knowledge and experience with transsexual and transgender individuals.

c. Form DBPR FSBC 21, “Therapeutic Use Exemption and Medical Condition Explanation Form,”  March 2014, as adopted and incorporated in Rule 61K1-3.007, F.A.C. and a letter from the board certified physician responsible for the care of the participant will need to be submitted to the commission, and shall include the following:

i. Initial date of hormone therapy for the assigned sex (male);

ii. Date, location, surgeon, and surgical report of any surgery including breast reduction, gonadectomy, hysterectomy, or any other surgery involving genitalia;

iii. Hormone name/type, dose, and interval of administration over the past two years;

v. Lab reports of estradiol and testosterone levels within the past two years with a goal of serum estradiol levels within the normal range for a healthy man and testosterone levels within the range for healthy men, as determined under lab specific ranges as set forth below;

vi. Name, dose, and duration of any anti-estrogen treatment used over the past two years;

vii. Name, dose, and duration of any other medication used as part of the management of the transgender state.

c.d. No change.

i. through iii. No change.

(c) Pre-Fight and day of Fight:

1.Participants should submit laboratory lab data required above which has been drawn from the participant no more than 6 months prior to the match date, including one value within one month of the match.  Participants shall not be permitted to participate if their estradiol or total testosterone levels are outside of the normal range.  If a value is found to be out of the normal range, the participant shall take action to correct the level by repeating the laboratory test lab and/or adjusting medication appropriately, which must be documented in an additional Form DBPR FSBC 20 21, “Pre Licensure Physical Sheet” effective 2014, adopted and incorporated herein. “Therapeutic Use Exemption and Medical Condition Explanation Form,” August 2013, completed by the physician who provided the letter and original Form DBPR FSBC 21, “Therapeutic Use Exemption and Medical Condition Explanation Form,” March 2014, as required above.

2. No change.

(11) All medical information provided to the commission directly shall not be released to any individual or entity without prior disclosure to the participants and only for the express purpose of determining the ability to participate in a match. Such medical information may be released to ringside physicians or representatives of the commission or the commission office. Participants shall sign Form DBPR FSBC 20 21, “Pre-Licensure Physical Sheet” “Therapeutic Use Exemption and Medical Condition Explanation Form,” effective March 2014, adopted and incorporated by reference in Rule 61K1-3.007, F.A.C. as a release to permit the commission to release the medical information to the necessary individuals prior to the match for the express purpose of determining fitness to participate in a match.

(12) Participants who have had prior pertinent medical conditions identified by their physician on Form DBPR FSBC 20, “Pre-Licensure Physical Info Sheet,” effective March 2014, may not participate in a match until the participant has been cleared by a ringside physician. Participants with preexisting medical conditions should have their physician who provided treatment for the preexisting medical condition, or the physician who conducted the physical, to complete Form DBPR FSBC 21, “Therapeutic Use Exemption and Medical Condition Explanation Form,” March 2014, for review prior to the match. If the commission office determines that the participant’s health or his or her opponent’s health is at risk due to the preexisting medical condition, the commission office shall refuse to permit the participant to participate. The commission office may request additional medical tests to determine whether a preexisting medical condition is a threat to the participant or his or her opponent.

(13) No change.

(14) The executive director or his or her designee shall, whenever necessary, require that a referee undergo a physical examination prior to acting as a referee in any match.

 

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Paul Waters, Executive Director, Florida State Boxing Commission, 1940 North Monroe Street, Tallahassee, Florida 32399-2202